As of 2025-07-06, the Fair Value of Plus Therapeutics Inc (PSTV) is -2.36 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.30 USD, the upside of Plus Therapeutics Inc is -896.02%.
With the market price of 0.30 USD and our fair value calculation, Plus Therapeutics Inc (PSTV) is not a good investment. Investing in PSTV stocks now will result in a potential loss of 896.02%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -8.24 | -13.40 | -20.28 | -13.32 | -12.98 | -13.64 |
| YoY growth | 24.33% | -62.62% | -51.34% | 34.34% | 2.54% | -10.55% |
| Market Cap (mil) | 17.03 |
| P/E | |
| Forward P/E |
| EPS | -0.47 |
| Avg earnings growth rate | -10.55% |
| TTM earnings | -27.12 |